Rigel Pharmaceuticals Total Assets:
310.04M for Dec. 31, 2012Rigel Pharmaceuticals Historical Total Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 310.04M |
| Sept. 30, 2012 | 194.32M |
| June 30, 2012 | 214.36M |
| March 31, 2012 | 233.91M |
| Dec. 31, 2011 | 257.11M |
| Sept. 30, 2011 | 275.86M |
| June 30, 2011 | 289.87M |
| March 31, 2011 | 165.67M |
| Dec. 31, 2010 | 186.70M |
| Sept. 30, 2010 | 201.00M |
| June 30, 2010 | 195.91M |
| March 31, 2010 | 217.14M |
| Dec. 31, 2009 | 140.74M |
| Sept. 30, 2009 | 164.30M |
| June 30, 2009 | 88.22M |
| March 31, 2009 | 114.03M |
| Dec. 31, 2008 | 143.86M |
| Sept. 30, 2008 | 168.58M |
| June 30, 2008 | 194.68M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Total Assets
The sum of all current and long-term assets held by a company. An asset is any item with economic value that is held by a company.
Learn More
RIGL Total Assets Benchmarks
| Companies | |
|---|---|
| AstraZeneca | 52.33B |
| MEI Pharma | 27.58M |
| Lannett Company | 168.38M |
RIGL Total Assets Rankings
| Overall |
59th percentile 3269 of 8002 |
| Sector |
71st percentile 198 of 684 in Healthcare |
| Industry |
70th percentile 20 of 68 in Drug Manufacturers - Specialty & Generic |
RIGL Total Assets Range, Past 5 Years
| Minimum | 88.22M | Jun 2009 |
| Maximum | 310.04M | Dec 2012 |
| Average | 197.70M |